What are the appropriate patient selection criteria, peri‑operative management steps, and alternative surgical options for a VNOTES (vaginal natural orifice transluminal endoscopic surgery) robotic hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

VNOTES Robotic Hysterectomy: Clinical Approach and Patient Selection

When hysterectomy is indicated for benign gynecologic conditions, VNOTES (vaginal natural orifice transluminal endoscopic surgery) with or without robotic assistance represents a highly effective minimally invasive approach that combines the advantages of vaginal surgery with endoscopic visualization, offering reduced postoperative pain, faster recovery, and shorter hospital stays compared to traditional laparoscopic approaches.

Surgical Approach Selection

Prioritizing the Least Invasive Route

The fundamental principle is clear: when hysterectomy is necessary, the least invasive route should always be performed 1. The hierarchy of invasiveness places vaginal approaches (including VNOTES) as superior to laparoscopic, which in turn is superior to abdominal hysterectomy. Vaginal hysterectomy is associated with shorter operating times, faster return to normal activities, and better quality of life compared to abdominal approaches 1.

VNOTES vs. Traditional Approaches

Recent evidence demonstrates that VNOTES hysterectomy consistently shows favorable perioperative outcomes including reduced operative time (90 vs. 135 minutes), lower blood loss (100 vs. 200 mL), decreased postoperative pain, and shorter hospital stays compared to laparoscopic-assisted vaginal hysterectomy (LAVH) 2, 3. Same-day discharge is achievable in over 94% of cases 4.

Patient Selection Criteria

Ideal Candidates

  • Benign gynecologic conditions requiring hysterectomy (fibroids, adenomyosis, abnormal bleeding)
  • Uterine size: VNOTES is feasible even with large uteri (median weights 340-370g reported, with cases up to 800g successfully completed) 4, 3
  • Obesity: VNOTES provides particular advantages in obese patients 2
  • Nulliparity: Not a contraindication; technique is feasible 2
  • Prior abdominal surgery/adhesions: VNOTES can be advantageous in these complex cases 2

Factors Influencing Operative Time

Regression analysis identifies these as significant predictors requiring consideration 3:

  • BMI (higher BMI increases complexity)
  • Uterine weight (larger uteri require more time but remain feasible)
  • Prior vaginal delivery (facilitates access)
  • History of abdominal surgery (may complicate but not contraindicate)

Relative Contraindications

  • Suspected malignancy (requires comprehensive staging)
  • Severe pelvic organ prolapse requiring concurrent repair via abdominal route
  • Inability to achieve adequate vaginal access

Robotic Assistance: When and Why

Conventional vs. Robotic VNOTES

Robotic assistance in VNOTES provides three-dimensional visualization, wristed instrumentation with enhanced dexterity, and surgeon-controlled camera movement, which helps overcome the challenging triangulation and caudal-to-cephalic visualization inherent to conventional VNOTES 5. However, robotic assistance increases operative time without significantly affecting blood loss or complication rates 3.

Specific Indications for Robotic VNOTES

  • Complex pathology requiring enhanced visualization and dexterity
  • Large uterine volume (median 370g in robotic series) 4
  • Concurrent procedures (bilateral salpingectomy, ovarian cystectomy) 5
  • Surgeon preference when experienced in robotic techniques
  • Cases where conventional VNOTES triangulation would be particularly challenging

Single-Port Robotic System

The da Vinci Single-Port (SP) system is specifically designed for narrow anatomical spaces and shows excellent feasibility for robotic-assisted vaginal hysterectomy 4, 6. Median total operative time is 74 minutes with the SP system, with minimal blood loss and no conversions reported 4.

Perioperative Management Steps

Preoperative Planning

  1. Exclude malignancy: Endometrial biopsy is essential before any hysterectomy, particularly in postmenopausal patients or those with persistent abnormal bleeding 1
  2. Imaging assessment: Not routinely required for benign disease, but consider if uterine size or anatomy unclear
  3. Optimize medical comorbidities: Particularly important given potential for same-day discharge

Surgical Technique (Robotic VNOTES)

  1. Colpotomy: Anterior and posterior colpotomy performed
  2. Uterosacral ligament detachment: Bilateral detachment
  3. Port placement:
    • Alexis ring inserted transvaginally
    • GelPoint trocars arranged in diamond configuration on GelSeal cap
    • Pneumoperitoneum established
  4. Patient positioning: Trendelenburg position
  5. Robot docking: Camera trocar inserted first, followed by two additional trocars with appropriate spacing to avoid arm collision 5
  6. Procedure completion: Hysterectomy with concurrent procedures as indicated
  7. Specimen extraction: Through vaginal access

Postoperative Management

  • Pain control: Minimal postoperative pain expected (median VAS score 0 at 4 hours) 4
  • Discharge planning: Same-day discharge in >94% of cases 4
  • Activity restrictions: Faster return to normal activities compared to laparoscopic approaches 2

Learning Curve

The learning curve for VNOTES is relatively short, supporting broad clinical adoption 2. For robotic single-port VNOTES specifically:

  • Hysterectomy time stabilizes after approximately 30 cases
  • Port placement plateaus after 43 cases
  • Docking time plateaus after 37 cases 6

Proficiency is achieved more rapidly among surgeons with prior experience in robotic-assisted single-site and conventional VNOTES techniques 6.

Alternative Surgical Options

When VNOTES is not feasible or appropriate:

1. Traditional Vaginal Hysterectomy

  • Preferred when endoscopic visualization not required
  • Shorter operative time than VNOTES in straightforward cases

2. Laparoscopic Hysterectomy

  • When vaginal access inadequate
  • Associated with faster return to activities and shorter hospital stays compared to abdominal approach 1
  • Robotic-assisted laparoscopic hysterectomy shows similar outcomes to traditional laparoscopy in terms of operative time, hospital stay, and postoperative complications 1

3. Abdominal Hysterectomy

  • Reserved for cases where minimally invasive approaches not feasible
  • Associated with longer hospital stay, recovery time, greater pain, and higher infection risk 1

4. Uterine-Sparing Alternatives

Consider before hysterectomy when fertility preservation desired or patient preference:

  • Uterine artery embolization (UAE): Equally effective at reducing heavy menstrual bleeding at 4 years compared to myomectomy, with lower reintervention rates than myomectomy 1
  • Myomectomy (hysteroscopic, laparoscopic, or open): For fibroid-related symptoms with fertility preservation
  • Medical management: First-line for many patients (progestin IUDs, combined oral contraceptives, GnRH antagonists)

Critical Caveats

Complications to Monitor

  • Intraoperative hematuria: Higher rate with VNOTES (3.8%) compared to LAVH (0.5%), though overall complication rates similar 3
  • Bladder injury risk: Requires careful technique during anterior colpotomy
  • Conversion rate: Extremely low (<1%) in experienced hands 6
  • No conversions to laparotomy reported in recent series 4, 3

Long-term Considerations

Even when hysterectomy is necessary, counsel patients that hysterectomy carries long-term risks including increased cardiovascular disease, osteoporosis, bone fracture, and dementia, even with ovarian conservation 1. These risks are particularly elevated when performed at young age 1. This underscores why less invasive alternatives should be exhausted first when appropriate.

Training Requirements

Successful dissemination of VNOTES relies on:

  • Structured training programs
  • Standardized guidelines
  • Device development
  • Long-term safety data collection 2

References

1
Guideline

acr appropriateness criteria® management of uterine fibroids: 2023 update.

Journal of the American College of Radiology, 2024

Related Questions

What is the step‑by‑step technique for performing a robotic‑assisted vaginal hysterectomy in an adult woman with benign uterine disease whose uterus fits through the vagina, has adequate vaginal access, no severe pelvic adhesions, and no contraindications to laparoscopy?
What is the appropriate stepwise management and workup for a female patient who had two episodes of sharp chest pain radiating to the jaw, each lasting about 10 seconds?
In an infant with mitochondrial DNA depletion syndrome 4A (Alpers type) presenting with refractory seizures and progressive liver failure, what are the recommended seizure medications and steps to avoid hepatotoxic drugs?
How should dizziness occurring after an ear infection be evaluated and treated?
What is the emergency management for a patient with acute dysphagia and lethargy?
What is the anatomical and physiological classification of the airway?
What is the recommended allogeneic hematopoietic stem cell transplant procedure (including conditioning regimen, donor stem cell collection, graft‑versus‑host disease prophylaxis, and supportive care) for a patient under 70 years old with adequate cardiac, pulmonary, hepatic, and renal function and an HLA‑matched donor?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.